If you or someone you love has been diagnosed with, or is being evaluated for, a health condition related to the TTN gene, you may be encountering unfamiliar terms such as titin myopathy, titin muscular dystrophy, titinopathy, TTN-related disorder, or TTN gene disorder. Learning that a genetic change may be affecting your muscles or heart can bring many questions, especially because TTN-related conditions are complex and can vary greatly from one person to another.
The first thing we want you to know is that you are not alone. Team Titin is here to help you learn more, find reliable information, and connect with others in the TTN community.
What is titin?
The TTN gene provides instructions for making a protein called titin. Titin is the largest known human protein and is found in skeletal and heart muscle.
Inside muscle cells, titin is an important part of the sarcomere, the basic working unit of a striated muscle cell that helps it contract and relax. Titin also helps support the structure and elasticity of muscle. Because titin plays such an important role in muscle function, certain disease-causing changes in the TTN gene can affect skeletal muscle, meaning the muscles that move or support the body, the heart, or both.
Changes in a gene are commonly called “variants”. You may also hear the older term “mutation”. Not every TTN variant causes disease, which is one reason interpreting TTN genetic test results can be complicated.
What is titin myopathy, and what does titinopathy mean?
Titin myopathy refers to genetic muscle conditions caused by disease-causing variants involving the TTN gene. These conditions are part of a broader group of TTN-related disorders often called titinopathies.
Titinopathy is a broad term because TTN-related disease can affect skeletal muscle, heart muscle, or both. Some people primarily have skeletal muscle weakness. Others primarily develop heart disease. Some people experience both skeletal muscle and heart involvement.
When TTN affects skeletal muscle, it may be described as a genetic muscle condition, neuromuscular condition, titinopathy, myopathy, or muscular dystrophy. Some TTN-related muscle conditions begin before or at birth or during childhood and may be classified as congenital myopathies. Others begin later in life. Not all titin myopathies are congenital, and not all are inherited in the same way.
Why can TTN-related conditions look so different?
One of the most important things to understand about titin myopathy is that symptoms and severity can vary widely.
TTN is an exceptionally large and complex gene. Different disease-causing variants can affect different regions of the gene and different parts of the titin protein. The type and location of a variant, how it is inherited, and other genetic and health factors can all influence how a TTN-related condition appears.
For one person, muscle weakness may be mild and develop later in life. Another person may have weakness beginning before birth, in infancy, or in childhood. Some people may develop breathing muscle weakness, mobility challenges, fatigue, or heart problems, while others may not. Even people in the same family who carry the same TTN variant can sometimes be affected differently.
Another person’s experience does not necessarily predict what your own experience will be. Your healthcare team can help interpret your individual genetic findings, symptoms, and family history.
What kinds of muscle conditions are associated with TTN?
Researchers have identified a growing spectrum of skeletal muscle disorders associated with disease-causing TTN variants. Many of these are rare muscle diseases. The conditions can be grouped broadly by how they are inherited.
Autosomal recessive titinopathies
In recessive conditions, disease-causing variants are present in both copies of the TTN gene. Recessive TTN-related disease can include congenital and childhood-onset myopathies, sometimes with heart involvement. Described phenotypes include forms of congenital titinopathy, limb-girdle muscular dystrophy R10 (LGMDR10), Salih myopathy, centronuclear or multi-minicore/core myopathy, and other early-onset muscle disorders.
Autosomal dominant titinopathies
In dominant conditions, a disease-causing variant in one copy of TTN can cause disease. Examples include hereditary myopathy with early respiratory failure (HMERF) and Udd distal myopathy, also called tibial muscular dystrophy, among other dominant TTN-related muscle conditions. These disorders may begin in adulthood and can have patterns of weakness that differ from congenital titinopathies.
Digenic TTN-related myopathy
Researchers have also described a rare form of titinopathy in which disease-causing changes involving both TTN and another gene called SRPK3 work together to cause disease.
Knowledge about TTN-related disease continues to grow. The specific name used for a person’s condition may depend on their genetic findings, symptoms, age of onset, inheritance pattern, muscle findings, and other clinical information.
What symptoms can occur with titin myopathy?
Symptoms depend on the specific TTN-related condition and can range from mild to severe. Possible features may include:
- Muscle weakness affecting the trunk, hips, shoulders, legs, feet, breathing muscles, or other muscle groups
- Delayed motor development or difficulty with mobility
- Fatigue, reduced endurance, or difficulty with activities that require muscle strength or endurance
- Breathing muscle weakness
- Contractures, which are shortening or tightening of muscles and tendons that can limit joint movement
- Scoliosis, or curvature of the spine, and other orthopedic concerns
- Cardiomyopathy (heart muscle disease)
- Abnormal heart rhythms, such as atrial fibrillation or ventricular tachycardia
This list is not comprehensive and is not meant to predict what any one person will experience. An expert clinician can help determine whether symptoms are related to your TTN variant.
Can TTN variants affect the heart?
Yes. The heart is also a muscle, and titin plays an essential role in heart muscle cells.
Certain disease-causing TTN variants, particularly TTN truncating variants (TTNtv), are among the most common genetic causes of inherited dilated cardiomyopathy (DCM). Dilated cardiomyopathy is a condition in which the heart becomes enlarged and has difficulty pumping blood effectively. TTN-related heart disease can also be associated with abnormal heart rhythms, including atrial fibrillation or ventricular tachycardia.
Not everyone with a disease-causing TTN variant will develop heart disease, and among those who do, the type and severity can vary. People with a confirmed TTN-related disorder or a pathogenic or likely pathogenic TTN variant should discuss appropriate cardiac evaluation and follow-up with their healthcare team, even if they currently feel well.
What does a TTN genetic test result mean?
Understanding a TTN genetic test report can be challenging. Finding a variant in the TTN gene does not automatically mean that the variant is causing disease. Genetic test results are usually classified as follows:
Pathogenic or likely pathogenic: There is strong evidence that the variant causes or contributes to disease.
Variant of uncertain significance (VUS): There is not currently enough evidence to determine whether the variant causes disease. A VUS does not confirm a TTN-related diagnosis and should be interpreted with the help of a genetics professional.
Likely benign or benign: Evidence indicates that the variant is unlikely to cause disease.
TTN is especially complicated because it is such a large gene and many genetic differences can be found in healthy people. The significance of a TTN variant should ideally be interpreted by clinicians and genetics professionals familiar with titin, in the context of the person’s symptoms, family history, inheritance pattern, and the variant’s location and predicted effect. In some cases, testing additional family members or other specialized studies may provide additional information about a variant.
A neurologist, cardiologist, medical geneticist, or genetic counselor familiar with neuromuscular or inherited heart conditions can help interpret genetic findings in the context of your health and family history.
What should I do after learning about a TTN-related diagnosis?
Knowledge about TTN-related muscle and heart conditions has grown considerably, but these may be rare conditions and not every healthcare provider will have extensive experience with titinopathy. Learning about your condition can help you become an informed partner in your care.
Depending on your individual diagnosis and symptoms, care may involve specialists in neuromuscular medicine, cardiology, pulmonology, rehabilitation, genetics, physical or occupational therapy and other areas. Care should be individualized, and your healthcare team can help determine what evaluations and follow-up are appropriate for you.
You are not alone
Being diagnosed with a rare muscle disease, heart disease, or genetic condition can bring many questions. You do not have to find all of the answers at once.
Research into the TTN gene, titin protein, titin myopathy, and TTN-related heart disease continues to advance. At the same time, families, clinicians, researchers, and advocates around the world are working together to improve understanding, care, and future treatments.
Team Titin, Inc. is a 501(c)(3) nonprofit organization that unites families, clinicians, and researchers to improve the lives of those affected by titin (TTN)-related muscle and heart conditions, building a stronger community through connection, advocacy, care, and research.
Continue exploring Team Titin’s information on genetics, care, research, and resources to help people living with TTN-related conditions navigate this journey in partnership with your medical team.
We welcome you to the Team Titin community and are here to help you on your journey.
Medical disclaimer: Information on this site is provided as an information resource only and is not to be used or relied on for any diagnostic or treatment purposes. Please connect with your personal treating medical team for professional diagnosis and treatment.